Design, synthesis, and biological evaluation of novel 8-substituted quercetin derivatives targeting the β‑catenin/B-cell lymphoma 9 interaction
Bioorganic & Medicinal Chemistry Letters · 2024
DOI: 10.1016/j.bmcl.2023.129591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2024. Verfasst von Xinyan Peng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200123, China; Shanghai Institute of Pharmaceutical Industry Co., Ltd, China …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Lymphoma, B-Cell, Neoplasms, Quercetin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
The β-catenin/B-cell lymphoma 9 (BCL9) protein-protein interaction (PPI) is a potential target for aberrantly active Wnt/β-catenin signaling which actively participates in initiating and progressing of many cancers. Herein, we discovered novel 8-substituted quercetin derivatives with potential inhibitory activities targeting β-catenin/BCL9 PPI. Among all the derivatives, compound B4 displayed the most promising PPI inhibitory activity with an IC50 value of 2.25 μM in a competitive fluorescence polarization assay and a KD value of 1.44 μM for the β-catenin protein. Furthermore, B4 selectively inhibited the growth of colorectal cancer (CRC) cells, suppressed the transactivation of Wnt signaling, and downregulated the expression of oncogenic Wnt target gene. Especially, B4 showed potent anti-CRC activity in vivo with the tumor growth inhibition (TGI) of 75.99 % and regulated the tumor immune microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200123, China; Shanghai Institute of Pharmaceutical Industry Co., Ltd, China State Institute of Pharmaceutical Industry, Shanghai 201203, China.
- School of Pharmacy, Fudan University, Shanghai 201203, China.
- Shanghai Institute of Pharmaceutical Industry Co., Ltd, China State Institute of Pharmaceutical Industry, Shanghai 201203, China.
- Shanghai Institute of Pharmaceutical Industry Co., Ltd, China State Institute of Pharmaceutical Industry, Shanghai 201203, China; School of Pharmacy, Fudan University, Shanghai 201203, China.
- Shanghai Institute of Pharmaceutical Industry Co., Ltd, China State Institute of Pharmaceutical Industry, Shanghai 201203, China; School of Chemistry and Chemical Engineering, Shanghai University of Engineering Science,…
- Shanghai Institute of Pharmaceutical Industry Co., Ltd, China State Institute of Pharmaceutical Industry, Shanghai 201203, China; National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutic…
Zitieren
APA
Peng, X., Shen, L. A., Bao, Y., Liu, C., Chen, Q., Zhang, H., Li, J., & Zhang, Q. (2024). Design, synthesis, and biological evaluation of novel 8-substituted quercetin derivatives targeting the β‑catenin/B-cell lymphoma 9 interaction. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2023.129591
Vancouver
Peng X, Shen LA, Bao Y, Liu C, Chen Q, Zhang H, et al. Design, synthesis, and biological evaluation of novel 8-substituted quercetin derivatives targeting the β‑catenin/B-cell lymphoma 9 interaction. Bioorganic & Medicinal Chemistry Letters. 2024. doi:10.1016/j.bmcl.2023.129591
BibTeX
@article{Peng2024,
author = {Peng, Xinyan and Shen, Li-An and Bao, Ya and Liu, Chenglong and Chen, Qiushi and Zhang, Hao and Li, Jiayi and Zhang, Qingwei},
title = {Design, synthesis, and biological evaluation of novel 8-substituted quercetin derivatives targeting the β‑catenin/B-cell lymphoma 9 interaction},
journal = {Bioorganic & Medicinal Chemistry Letters},
year = {2024},
doi = {10.1016/j.bmcl.2023.129591}
}
EUVIMED